Amarastesia Sàrl

Amarastesia's focus is on safety in gynecological procedures

Amarastesia is a Femtech, Medtech Startup based in Switzerland with the goal to revolutionize gynecological care and to close the gap on access to care, for 60% of women living in the Rural area and with limited access to specialized care. By developing atraumatic and minimally invasive devices that are pain-free, anesthesia-free and user friendly, Amarastesia will empower family practitioners and midwives in the rural area, therefore increasing access to care for all women, globally. Our first device CerAMvix provides a pain-free and anesthesia-free uterine access for gynecological procedures with an accent in the outpatient setting. Patented technology, cerAMvix significantly improves surgical efficiency, safety and patient's comfort, reducing overall healthcare costs.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

17.03.2025

Tech4Eva Pitch Event

Deal

17.03.2025

Start-Up Ecosystem Expedition in Paris with Innosuisse

Milestone

20.02.2025

2 Million Term Sheet Signed

Deal

02.02.2025

Jura Economic Promotion Funding

Deal

16.01.2025

FDA meeting, 510 K pathway

Show more...

No Jobs

Videos

KOLs testimony

virtual prototype/spine surgery

virtual prototype

Documents

No Awards

Amarastesia Sàrl

Amarastesia's focus is on safety in gynecological procedures

Headquarter:
Courroux

Foundation Date:
July 2024

Technology:

  • Medtech

Sectors:

  • Consumer products
  • Cosmetics
  • Cancer
  • Diagnostics
  • Hightech
  • Instruments
  • Healthcare infrastructure
  • Medical devices
  • Medtech
  • Research and development
  • Services for companies
  • Services for consumers